TRITON3 Phase 3 Trial of Rubraca® (rucaparib) Achieves Primary Endpoint in Men with Metastatic Castration-Resistant Prostate Cancer with BRCA or ATM Mutations
Stock Information for Clovis Oncology Inc.
Loading
Please wait while we load your information from QuoteMedia.